Expression of platelet-derived growth factor in the vascular walls of patients with lower extremity arterial occlusive disease

被引:18
作者
Zhang, Yang [1 ]
Zhang, Wang-De [1 ]
Wang, Ke-Qin [1 ]
Li, Tan [1 ]
Song, Sheng-Han [1 ]
Yuan, Biao [1 ]
机构
[1] Capital Univ Med Sci, Beijing Chaoyang Hosp, Dept Vasc Surg, Beijing 100020, Peoples R China
关键词
arteriosclerosis obliterans; platelet-derived growth factor; quantitative polymerase chain reaction; NF-KAPPA-B; HUMAN CORONARY-ARTERIES; ATHEROSCLEROSIS; RECEPTOR; ANGIOPLASTY; INHIBITION; CHAIN;
D O I
10.3892/etm.2015.2275
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The aim of the present study was to quantitatively analyze the expression of platelet-derived growth factor (PDGF)-A and PDGF-B in the vascular walls of patients with lower extremity arterial occlusive disease (LEAOD). The expression levels of PDGF-A and PDGF-B in the lower extremity arteries of 19 LEAOD patients (case group) and three healthy subjects (control group) was determined using quantitative polymerase chain reaction. Intergroup comparisons revealed that the relative mRNA expression levels were higher in the case group, as compared with the control group, for PDGF-A (34.38 +/- 5.80 vs. 21.94 +/- 1.05; P<0.05) and PDGF-B (33.95 +/- 5.92 vs. 24.15 +/- 3.12; P<0.05). In addition, the expression of PDGF-A revealed a positive linear correlation with the expression of PDGF-B (P<0.05). Therefore, the expression levels of PDGF-A and PDGF-B were found to be higher in the vascular walls of LEAOD patients, while the expression of PDGF-A was found to correlate with the expression of PDGF-B. A significant increase in the expression levlels of PDGF-A and PDGF-B were observed in the vascular walls of patients with LEAOD, and the expression of PDGF-A was associated with the expression of PDGF-B.
引用
收藏
页码:1223 / 1228
页数:6
相关论文
共 25 条
[1]   Endothelial/pericyte interactions [J].
Armulik, A ;
Abramsson, A ;
Betsholtz, C .
CIRCULATION RESEARCH, 2005, 97 (06) :512-523
[2]   Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice [J].
Caligiuri, G ;
Rudling, M ;
Ollivier, V ;
Jacob, MP ;
Michel, JB ;
Hansson, GK ;
Nicoletti, A .
MOLECULAR MEDICINE, 2003, 9 (1-2) :10-17
[3]   INHIBITION OF NEOINTIMAL SMOOTH-MUSCLE ACCUMULATION AFTER ANGIOPLASTY BY AN ANTIBODY TO PDGF [J].
FERNS, GAA ;
RAINES, EW ;
SPRUGEL, KH ;
MOTANI, AS ;
REIDY, MA ;
ROSS, R .
SCIENCE, 1991, 253 (5024) :1129-1132
[4]   Infectious agents, inflammation, and growth factors:: How do they interact in the progression or stabilization of mild human atherosclerotic lesions? [J].
Gois, Jose ;
Higuchi, Maria ;
Reis, Marcia ;
Diament, Jayme ;
Sousa, Januario ;
Ramires, Jose ;
Oliveira, Sergio .
ANNALS OF VASCULAR SURGERY, 2006, 20 (05) :638-645
[5]   PLATELET-DERIVED GROWTH-FACTOR IS A CHEMOATTRACTANT FOR VASCULAR SMOOTH-MUSCLE CELLS [J].
GROTENDORST, GR ;
CHANG, T ;
SEPPA, HEJ ;
KLEINMAN, HK ;
MARTIN, GR .
JOURNAL OF CELLULAR PHYSIOLOGY, 1982, 113 (02) :261-266
[6]   A20, a regulator of NFκB, maps to an atherosclerosis locus and differs between parental sensitive C57BL/6J and resistant FVB/N strains [J].
Idel, S ;
Dansky, HM ;
Breslow, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) :14235-14240
[7]  
Kenagy RD, 1997, CIRCULATION, V96, P3555
[8]   Pathobiology of atherosclerosis - a brief review [J].
Kher, N ;
Marsh, JD .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2004, 30 (06) :665-672
[9]   Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice [J].
Kozaki, K ;
Kaminski, WE ;
Tang, JJ ;
Hollenbach, S ;
Lindahl, P ;
Sullivan, C ;
Yu, JC ;
Abe, K ;
Martin, PJ ;
Ross, R ;
Betsholtz, C ;
Giese, NA ;
Raines, EW .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (04) :1395-1407
[10]   Possible new role for NF-κB in the resolution of inflammation [J].
Lawrence, T ;
Gilroy, DW ;
Colville-Nash, PR ;
Willoughby, DA .
NATURE MEDICINE, 2001, 7 (12) :1291-1297